Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Dec;7(6):100596.
doi: 10.1016/j.esmoop.2022.100596. Epub 2022 Oct 12.

Expanding the role of systemic therapy for patients with active, HER2-positive breast cancer brain metastases

N U Lin  1
Affiliations
Editorial

Expanding the role of systemic therapy for patients with active, HER2-positive breast cancer brain metastases

N U Lin. ESMO Open. 2022 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclosure The author has declared no conflicts of interest.

References

    1. Pestalozzi B.C., Holmes E., de Azambuja E., et al. CNS relapses in patients with HER2-positive early breast cancer who have and have not received adjuvant trastuzumab: a retrospective substudy of the HERA trial (BIG 1-01) Lancet Oncol. 2013;14(3):244–248. - PubMed
    1. Lin N.U. Reevaluating the role of antibody–drug conjugates in the treatment of patients with brain metastases. Ann Oncol. 2020;31(10):1279–1281. - PubMed
    1. Ramakrishna N., Anders C.K., Lin N.U., et al. Management of advanced human epidermal growth factor receptor 2–positive breast cancer and brain metastases: ASCO guideline update. J Clin Oncol. 2022;40(23):2636–2655. - PubMed
    1. Cortés J., Kim S.B., Chung W.P., et al. Trastuzumab deruxtecan versus trastuzumab emtansine for breast cancer. N Engl J Med. 2022;386(12):1143–1154. - PubMed
    1. Gennari A., André F., Barrios C.H., et al. ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer. Ann Oncol. 2021;32(12):1475–1495. - PubMed

Publication types